InvestorNewsBreaks – SOHM, Inc. (SHMN) Continues to Advance Groundbreaking Technology
May 22, 2024
SOHM (OTC: SHMN), a leading generic pharmaceutical and upstart biotechnology company, today announced its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. The technology holds the potential to revolutionize genome editing by allowing for precise and targeted integration of predesigned donor DNA into […]
SOHM, Inc., Targets Revolutionary New ABBIE Genome Editing Kits for Q3, 2024
May 22, 2024
CHINO HILLS, Calif., May 22, 2024 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN)– a leading generic pharmaceutical and upstart biotechnology company, is proud to announce its ongoing work on ABBIE (A Binding Based Integrase Enzyme), a revolutionary retroviral integrase with a linked dCas9 DNA binding domain. This groundbreaking technology has the […]
InvestorNewsBreaks – SOHM, Inc. (SHMN), Coastar Therapeutics Collaborate to Advance Field of Genome Editing
April 1, 2024
SOHM (OTC: SHMN), a cutting-edge biopharmaceutical company focused on gene editing technologies, today announced its collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems. The partnership aims to advance the field of genome editing using Coastar’s red blood cell membrane derived carriers and SOHM’s ABBIE (A Binding […]
SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers
April 1, 2024
CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) — viaIBN–SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems, and SOHM, a cutting-edge biopharmaceutical company […]
InvestorNewsBreaks – SOHM Inc. (SHMN) Announces Filing of Provisional Patent for ABBIE Smart Gene Editing Technology
January 9, 2024
SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, has filed a provisional patent application on its ABBIE Smart Gene-Editing platform. According to the announcement, the platform uses the latest enzymes and guide RNAs to resolve off-target gene-editing limitations. Gene therapy modifies or manipulates the […]
SOHM Files Provisional Patent on ABBIE’s ‘Smart Gene-Editing’ That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations
January 9, 2024
CHINO HILLS, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures and markets generic drugs covering numerous treatment categories, announces today the Company has filed a provisional patent application on its ABBIE “Smart Gene-Editing” platform that uses the latest enzymes […]
SOHM Inc. (SHMN) Releases New Product Line and Expands Manufacturing Operations in Carlsbad, California
December 15, 2023
SOHM (OTC: SHMN), a pharmaceutical, nutraceutical, and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, recently announced the launch of new products to the company’s catalog and expansion into a new CDMO GMP manufacturing facility in Carlsbad, California. SOHM is set to enter the global vitamin gummies market by launching 13 […]
InvestorNewsBreaks – Why SOHM Inc. (SHMN) Is ‘One to Watch’
December 14, 2023
SOHM (OTC: SHMN) is a recognized generic pharmaceutical manufacturer with operations spanning India, the Philippines, Uganda, the U.S., U.K. and EU. The company aims to create and produce cutting-edge generic medications that span a wide range of treatment areas, all while ensuring top-tier quality and keeping prices affordable. “With proficiency in both manufacturing and marketing, […]
SOHM Inc.’s (SHMN) New Gene-Editing Technology Holds Potential to Revolutionize the Field of Cardiology, With Superior Capabilities Over Other Gene-Editing Systems
December 13, 2023
Genome editing refers to the modification of a cell’s DNA (genome) to block, improve, restore or add gene expression and gene function. It may be used to modify genomic DNA of a cell or subject to correct or to provide a model for a genetic disease. The process alters the expression of the gene and […]
SOHM Inc. (SHMN) Taps into UACI’s Robust Resources and Specialized Infrastructure for ABBIE Advancement
December 11, 2023
SOHM (OTC: SHMN), a generic drug manufacturing and distributing innovator, just announced its development collaboration with the University of Arizona Center for Innovation (“UACI”) for the advancement of its revolutionary ABBIE platform. This marks a significant milestone for SOHM, notably as it anticipates monetizing ABBIE off-the-shelf, non-viral gene editing kits through licensing opportunities as early […]
InvestorNewsBreaks – SOHM, Inc. (SHMN) Announces 2024 Outlook for Business Units
December 5, 2023
SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, today announced its outlook for 2024 for each of its business units. SOHM is organized into the following business units: OTC Self-care (over-the-counter nutraceuticals and cosmeceuticals), Branded Generics (off-patent prescription pharmaceuticals), CDMO, Contract Development Manufacturing (contract […]
SOHM Announces Business Outlook for 2024
December 5, 2023
CHINO HILLS, Calif., Dec. 05, 2023 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical and cosmeceutical Company that manufactures and markets generic drugs covering numerous treatment categories, announced: SOHM Announces Business Outlook for 2024 for each of its Business Units. SOHM, Inc. is organized into the following business […]
SOHM Inc. (SHMN) Is ‘One to Watch’
November 27, 2023
SOHM (OTC: SHMN) is a generic pharmaceutical manufacturing and marketing company with a vision of “Globalè Prospèro” (Global Prosperity). SOHM was founded in 1998 and is headquartered in Chino Hills, California. The company’s primary goal is to create and produce cutting-edge generic medications that span a wide range of treatment areas, all while ensuring top-tier […]
InvestorNewsBreaks – SOHM, Inc. (SHMN) Launches Carlsbad-Based CDMO GMP Manufacturing Facility
November 21, 2023
SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, today announced the opening of its new manufacturing facility in Carlsbad, California, to meet the growing demand for its products. The facility will handle orders that SOHM has received and expects to receive in the near […]
SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California
November 21, 2023
CHINO HILLS, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced today its new manufacturing facility at Carlsbad. SOHM Announces New CDMO GMP Manufacturing Facility in Carlsbad, California. The company is excited to […]
InvestorNewsBreaks – SOHM Inc. (SHMN) Unveils New Suite of SOHM Nutrients’ Brand Chewables
November 14, 2023
SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, has announced a new suite of products in the vitamin gummies space. Provided by the SOHM OTC Self-Care business unit, the new line includes 13 new SOHM Nutrients’ Brand Chewables. The new suite of chewable products […]
SOHM OTC Self-care Launches Suite of 13 New SOHM Nutrients’ Brand Chewables
November 14, 2023
CHINO HILLS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announced: SOHM OTC Self-care launches a suite of 13 new SOHM Nutrients’ Brand Chewables. SOHM OTC Self-care business unit is launching its suite […]
InvestorNewsBreaks – SOHM Inc.’s (SHMN) ABBIE Technology Poised to Make a Difference in the Lives of Millions
November 9, 2023
SOHM (OTC: SHMN), a global generic drug innovator, recently completed the acquisition of a disruptive stem cell technology ABBIE (A Binding Based Integrating Enzyme) and patents from CGA Intellectual Holdings Inc. “[The acquisition] will allow the company to create regenerative medicine and cosmeceutical products for commercialization during the next year. SOHM’s acquisition of ABBIE grants […]
SOHM, Inc. (SHMN) Completes Acquisition of ABBIE Gene-editing Tech, Begins Preparations to Commercialize Solutions for Heart Disease
October 19, 2023
Global generic drug innovator SOHM (OTC: SHMN) is celebrating the fulfillment of its letter-of-intent to acquire a disruptive stem cell technology and patents from CGA Intellectual Holdings Inc., which will allow the company to create regenerative medicine and cosmeceutical products for commercialization during the next year. SOHM’s acquisition of ABBIE (A Binding Based Integrating Enzyme) […]
SOHM, Inc. (SHMN) Bolsters Executive Team; Confident About Anticipated Developments and Opportunities
October 17, 2023
SOHM (OTC: SHMN), a generic drug manufacturing and distributing innovator, is bolstering its executive team as it eyes the global nutraceuticals market, which is expected to post a CAGR of 9.4% between 2023 and 2030, and the global NSAID market which is also expected to be valued at $30 billion by 2030. SOHM’s strategic approach […]
InvestorNewsBreaks – SOHM, Inc. (SHMN), UACI Collaborate to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
October 10, 2023
SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, today announced its entry into development collaboration with the University of Arizona Center for Innovation (“UACI”) to propel ABBIE, a non-viral gene-editing kit technology. UACI is a leading science and tech startup incubator that is directly […]
SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
October 10, 2023
CHINO HILLS, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces: SOHM has entered into development collaboration with the University of Arizona Center for Innovation (UACI) to propel ABBIE, a non-viral gene-editing […]
InvestorNewsBreaks – SOHM, Inc. (SHMN) Announces Acquisition of World-Class Gene-Editing Platform
September 26, 2023
SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, today announced it has acquired ABBIE, a world-class gene-editing platform that can deliver genetic payloads using non-viral vectors. Through this acquisition, SOHM is well-positioned as a competitive player in the $5.3 billion gene-editing market in 2023, […]
SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors
September 26, 2023
CHINO HILLS, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today that it has acquired: ABBIE, a world-class gene-editing platform which can deliver genetic payloads using non-viral vectors. With this acquisition, SOHM […]
InvestorNewsBreaks – SOHM Inc. (SHMN) Expands Team to Direct Global Growth Strategy
September 22, 2023
SOHM (OTC: SHMN) is a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories. “SOHM is strengthening its governing team with the addition of two experienced visionaries committed to helping the company’s growth in the pharmaceutical, nutraceutical and cosmeceutical marketplace… The new officers are expected to help direct SOHM’s […]
Generic Drug Manufacturer SOHM, Inc. (SHMN) Building Regenerative Medicine Platform with LOI for Gene Editing Technology
September 20, 2023
Generic drug manufacturing and distributing innovator SOHM (OTC: SHMN) is an innovator in regenerative medicine, nutraceuticals and cosmeceuticals through the development of cost-effective generic drugs for the breadth of major treatment categories. The company’s drive to sustain the pharmaceutical drug supply chain has led it to pursue the acquisition of a disruptive stem cell technology […]
Leadership Changes At SOHM, Inc. (SHMN) to Strengthen Growth Strategies for Generic Drug Market and Gene Editing Platform Development
September 14, 2023
Generic drug manufacturing and distributing innovator SOHM (OTC: SHMN) is strengthening its governing team with the addition of two experienced visionaries committed to helping the company’s growth in the pharmaceutical, nutraceutical, and cosmeceutical marketplace. Dr. Krishna Bhat (MD, Ph.D, FACC), an experienced bioscientist and cardiologist, will bring his leadership skills to the company’s advisory board […]
InvestorNewsBreaks – SOHM Inc. (SHMN) Names Seasoned Veteran as VP of Quality
September 11, 2023
SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, has appointment a new vice president of quality. The company announced that Wm. Dewey Rushing will be serving as SOHM vice president for quality. Rushing has been serving on the company’s advisory board member and that […]
InvestorNewsBreaks – SOHM, Inc. (SHMN) Announces Strategic Board Appointment of Dr. Krishna Bhat, MD, Ph.D., FACC
August 24, 2023
SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, today announced the appointment of Dr. Krishna Bhat, MD, Ph.D., FACC, an experienced bioscientist and cardiologist, to serve on its advisory board as a chief medical advisor. According to the update, Dr. Bhat has a practice […]
SOHM, Inc. Expands Its Advisory Board, Appointing Dr. Krishna Bhat, M.D, Ph.D., FACC, as Chief Medical Advisor
August 24, 2023
CHINO HILLS, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) — via IBN — SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the appointment of Dr. Krishna Bhat, MD. Ph.D., FACC., an experienced bioscientist and cardiologist, to serve on the company’s Advisory Board as a Chief […]